A comprehensive review of the advances in neuromyelitis optica spectrum disorder

P Siriratnam, S Huda, H Butzkueven… - Autoimmunity …, 2023 - Elsevier
Neuromyelitis optica spectrum disorder (NMOSD) is a rare relapsing neuroinflammatory
autoimmune astrocytopathy, with a predilection for the optic nerves and spinal cord. Most …

Recent progress in epidemiology, clinical features, and therapy of multiple sclerosis in China

M Wang, C Liu, M Zou, Z Niu… - Therapeutic Advances …, 2023 - journals.sagepub.com
Multiple sclerosis (MS) is a demyelinating disease of the central nervous system
characterized by inflammation, demyelination, and neurodegeneration. It mainly affects …

Health utilities and costs for neuromyelitis optica spectrum disorder

DA Hughes, S Bourke, A Jones, R Bhatt… - Orphanet Journal of …, 2022 - Springer
Background Neuromyelitis optica spectrum disorder (NMOSD) is a rare, neurological
disease that places a significant burden on patients, their carers, and healthcare systems …

Barriers to access and unmet needs to neuromyelitis optica spectrum disorders care in an Argentinean cohort

V Tkachuk, MEB Aguirre, R Alonso, A Barboza… - Multiple sclerosis and …, 2023 - Elsevier
Introduction Neuromyelitis optica spectrum disorder (NMOSD) is a rare but severe
neuroimmunological condition associated with a significant financial burden. NMOSD is also …

Prodromes in demyelinating disorders, amyotrophic lateral sclerosis, Parkinson disease, and Alzheimer's dementia

RA Marrie, CJ Maxwell, DL Rotstein, CC Tsai… - Revue …, 2023 - Elsevier
A prodrome is an early set of symptoms, which indicates the onset of a disease; these
symptoms are often non-specific. Prodromal phases are now recognized in multiple central …

Clinical and epidemiological correlates of treatment change in patients with NMOSD: insights from the CIRCLES cohort

S Gholizadeh, A Exuzides, KE Lewis, C Palmer… - Journal of …, 2023 - Springer
Objective Neuromyelitis optica spectrum disorders (NMOSD) represent rare autoimmune
diseases of the central nervous system largely targeting optic nerve (s) and spinal cord. The …

Aligning payer and provider strategies with the latest evidence to optimize clinical outcomes for patients with neuromyelitis optica spectrum disorder

DM Wingerchuk, BG Weinshenker… - Journal of managed …, 2022 - jmcp.org
BACKGROUND: Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune
disorder affecting the central nervous system that is associated with significant morbidity and …

Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)

S Samadzadeh, R Adnan, P Berglova… - Frontiers in …, 2024 - frontiersin.org
Comorbidities in patients with multiple sclerosis (MS) and antibody-mediated diseases of the
central nervous system (CNS) including neuromyelitis optica spectrum disorder (NMOSD) …

Predictors of overlapping autoimmune disease in Neuromyelitis Optica Spectrum disorder (NMOSD): A retrospective analysis in two inner-city hospitals.

MR Alvarez, A Gurung, V Velayndhan… - Journal of the …, 2022 - Elsevier
Abstract Background The coexistence of Neuromyelitis Optica spectrum disorder (NMOSD)
with other autoimmune diseases (AD-NMOSD) presents worse clinical outcomes and …

NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis

AK Szewczyk, E Papuć, K Mitosek-Szewczyk, M Woś… - Brain Sciences, 2022 - mdpi.com
(1) Background: The emergence of white matter lesions in the central nervous system (CNS)
can lead to diagnostic dilemmas. They are a common radiological symptom and their …